Directors of the $12 billion California stem cell agency will meet at the end of this month to begin to tackle the sweeping, new tasks that voters have laid at their feet -- tasks that range from spending $1.5 billion on neurodegenerative diseases to creating affordable access to what are hoped to be nearly miraculous therapies for a host of terrible af…
California's Stem Cell Agency's Future
Planning a $5.5 Billion Course for the Next Five Years
